CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome
In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.
You May Also Like

高須幹弥(高須クリニック)切り抜きポッドキャスト
切り抜きスタジオ

Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio

Your Daily Dose
Dr Len Brancewicz, RPh, NMD

Meditation for Anxiety
Anxiety
दिनभर: पूरा दिन,पूरी ख़बर (Dinbhar)
BBC Hindi Radio

Daily Meditation
Daily Meditation Club

Digital Health Talks - Changemakers Focused on Fixing Healthcare
HealthIMPACT Live

The Real Truth About Health Free 17 Day Live Online Conference Podcast
Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne W

Erotic Short Stories: Read by Mia Hart
Sexuality and Erotica

I Choose Me with Jennie Garth
iHeartPodcasts
Community discussion